France's Minvasys releases Nile stent on market:
This article was originally published in Clinica
Minvasys, a French manufacturer and marketer of coronary balloons, stents and the proprietary vascular access system SuperKetch, has launched Nile, an intracoronary stent designed for easy and secured access to bifurcated arteries for the treatment of plaque. The product, described as a smart and simple device, has a specific delivery system for bifurcation lesions. It allows for the treatment of both the main and side branches simultaneously or sequentially. It was CE-marked in March 2004. The product addresses the 20% of the population with coronary diseases that have lesions at bifurcations, says Minvasys, which is based in Gennevilliers, in the Paris area. Minvasys has been in operation for one year, having been formed in May 2003.